Venera Bio-Tech Systems Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 03-01-2025
- Paid Up Capital ₹ 5.50 M
as on 03-01-2025
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.85 Cr
as on 03-01-2025
- Satisfied Charges ₹ 3.55 Cr
as on 03-01-2025
- Revenue -5.25%
(FY 2020)
- Profit 6.64%
(FY 2020)
- Ebitda -3.91%
(FY 2020)
- Net Worth 27.89%
(FY 2020)
- Total Assets 8.96%
(FY 2020)
About Venera Bio-Tech Systems
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 5.50 M.
The company currently has active open charges totaling ₹9.85 Cr. The company has closed loans amounting to ₹3.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Binhani, Murli Nair, and Arun Binhani serve as directors at the Company.
- CIN/LLPIN
U33110MH1999PTC122487
- Company No.
122487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Venera Bio-Tech Systems Private Limited offer?
Venera Bio-Tech Systems Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Industrial Autoclave & Sterilizers, Clean Room Equipment, Air Shower, Pharmaceutical Sterilizing Tunnel, Depyrogenation Tunnels, Commissioning Services, Cleanroom Equipment & Supplies, Pass Box, Laminar Air Flow.
Who are the key members and board of directors at Venera Bio-Tech Systems?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Binhani  | Director | 01-Nov-1999 | Current |
| Murli Nair | Director | 01-Nov-1999 | Current |
| Arun Binhani | Additional Director | 15-Nov-2024 | Current |
Financial Performance of Venera Bio-Tech Systems.
Venera Bio-Tech Systems Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 5.25% decrease. The company also saw a slight improvement in profitability, with a 6.64% increase in profit. The company's net worth Soared by an impressive increase of 27.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venera Bio-Tech Systems?
In 2020, Venera Bio-Tech Systems had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Oct 2023 | ₹1.20 M | Open |
Others Creation Date: 27 Jun 2023 | ₹3.60 Cr | Open |
Others Creation Date: 12 May 2022 | ₹1.60 Cr | Open |
How Many Employees Work at Venera Bio-Tech Systems?
Unlock and access historical data on people associated with Venera Bio-Tech Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venera Bio-Tech Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venera Bio-Tech Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
